{"chunk_id": "medquad__chunk_42125", "source": "medquad", "text": "ations are in the BRCA1 or BRCA2 gene. These gene mutations are described as \"\"high penetrance\"\" because they are associated with a high risk of developing ovarian cancer, breast cancer, and several other types of cancer in women. Compared to a 1.6 percent lifetime risk of developing ovarian cancer for women in the total population, the lifetime risk in women with a BRCA1 gene mutation is 40 to 60 percent, and the lifetime risk in women with a BRCA2 gene mutation is 20 to 35 percent. Men with mu"}